Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
- PGB2 cPLA2i 1.0 BCD110605C16 0.256 pmol/ml of medium
- PGB2 cPLA2i 1.0 BCD110605C18 0.311 pmol/ml of medium
- PGB2 cPLA2i 1.0 BCD110605C17 0.221 pmol/ml of medium
- PGB2 cPLA2i 4.0 BCD110605C34 0.149 pmol/ml of medium
- PGB2 cPLA2i 4.0 BCD110605C36 0.119 pmol/ml of medium
- PGB2 cPLA2i 4.0 BCD110605C35 0.066 pmol/ml of medium
- PGB2 cPLA2i 20.0 BCD110605C53 0.055 pmol/ml of medium
- PGB2 cPLA2i 20.0 BCD110605C54 0.655 pmol/ml of medium
- PGB2 cPLA2i 20.0 BCD110605C52 0.235 pmol/ml of medium
- PGB2 PLDi 1.0 BCD110605C10 0.164 pmol/ml of medium
- PGB2 PLDi 1.0 BCD110605C12 0.127 pmol/ml of medium
- PGB2 PLDi 1.0 BCD110605C11 0.245 pmol/ml of medium
- PGB2 PLDi 4.0 BCD110605C30 0.088 pmol/ml of medium
- PGB2 PLDi 4.0 BCD110605C29 0.406 pmol/ml of medium
- PGB2 PLDi 4.0 BCD110605C28 0.331 pmol/ml of medium
- PGB2 PLDi 20.0 BCD110605C48 0.199 pmol/ml of medium
- PGB2 PLDi 20.0 BCD110605C47 0.645 pmol/ml of medium
- PGB2 PLDi 20.0 BCD110605C46 0.386 pmol/ml of medium
- PGB2 KDO+cPLA2i 1.0 BCD110605C19 1.04 pmol/ml of medium
- PGB2 KDO+cPLA2i 1.0 BCD110605C21 0.509 pmol/ml of medium
- PGB2 KDO+cPLA2i 1.0 BCD110605C20 1.44 pmol/ml of medium
- PGB2 KDO+cPLA2i 4.0 BCD110605C39 2.36 pmol/ml of medium
- PGB2 KDO+cPLA2i 4.0 BCD110605C37 1.42 pmol/ml of medium
- PGB2 KDO+cPLA2i 4.0 BCD110605C38 1.94 pmol/ml of medium
- PGB2 KDO+cPLA2i 20.0 BCD110605C55 11.8 pmol/ml of medium
- PGB2 KDO+cPLA2i 20.0 BCD110605C57 17.4 pmol/ml of medium
- PGB2 KDO+cPLA2i 20.0 BCD110605C56 16.1 pmol/ml of medium
- PGB2 KDO+PLDi 1.0 BCD110605C15 0.524 pmol/ml of medium
- PGB2 KDO+PLDi 1.0 BCD110605C14 1.61 pmol/ml of medium
- PGB2 KDO+PLDi 1.0 BCD110605C13 1.3 pmol/ml of medium
- PGB2 KDO+PLDi 4.0 BCD110605C32 4.09 pmol/ml of medium
- PGB2 KDO+PLDi 4.0 BCD110605C31 4.8 pmol/ml of medium
- PGB2 KDO+PLDi 4.0 BCD110605C33 4.41 pmol/ml of medium
- PGB2 KDO+PLDi 20.0 BCD110605C49 18.7 pmol/ml of medium
- PGB2 KDO+PLDi 20.0 BCD110605C51 41.8 pmol/ml of medium
- PGB2 KDO+PLDi 20.0 BCD110605C50 41.1 pmol/ml of medium
- PGB2 KDO + ATP 1.0 BCD110605C07 1.32 pmol/ml of medium
- PGB2 KDO + ATP 1.0 BCD110605C09 2.03 pmol/ml of medium
- PGB2 KDO + ATP 1.0 BCD110605C08 1.81 pmol/ml of medium
- PGB2 KDO + ATP 4.0 BCD110605C25 5.68 pmol/ml of medium
- PGB2 KDO + ATP 4.0 BCD110605C26 6.81 pmol/ml of medium
- PGB2 KDO + ATP 4.0 BCD110605C27 5.27 pmol/ml of medium
- PGB2 KDO + ATP 20.0 BCD110605C45 35.6 pmol/ml of medium
- PGB2 KDO + ATP 20.0 BCD110605C43 29.2 pmol/ml of medium
- PGB2 KDO + ATP 20.0 BCD110605C44 37.2 pmol/ml of medium
- PGB2 C 0.0 BCD110605C02 0.472 pmol/ml of medium
- PGB2 C 0.0 BCD110605C01 0.585 pmol/ml of medium
- PGB2 C 0.0 BCD110605C03 0.339 pmol/ml of medium
- PGB2 C 1.0 BCD110605C06 0.159 pmol/ml of medium
- PGB2 C 1.0 BCD110605C05 0.23 pmol/ml of medium